Author avatar

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Recent Posts

2025-06-15 13:59:35

Lugdunin

Lugdunin is a microbiome-derived cyclic peptide antibiotic with direct anti-S. aureus activity and host immune-boosting effects. It induces L-37 and XCL8, recruits immune cells, and synergizes with host peptides, making it a promising candidate for RSA and atopic dermatitis interventions.